|
A8106
|
|
Altanserin hydrochloride hydrate ≥98% (HPLC), solid
|
Altanserin hydrochloride hydrate is a specific 5-HT2/serotonergic antagonist.
|
|
|
|
|
|
A7861
|
|
Asenapine maleate ≥98% (HPLC)
|
Asenapine maleate is a 5-HT receptor antagonist (5-HT1A,1B, 5-HT2A, 2B, 2C, 5-HT5A, 5-HT6 and 5-HT7), a D2 antagonist, and an antipsychotic.
|
|
|
|
|
|
C0832
|
|
Clozapine N-oxide
|
5-HT2 serotonin receptor antagonist; major metabolite of clopazine that can be monitored by HPLC.
|
|
|
|
|
|
C238
|
|
S(−)-Cyanopindolol hemifumarate salt solid, ≥98% (HPLC)
|
5-HT1A/1B serotonin receptor antagonist; β3-adrenoceptor antagonist.
|
|
|
|
|
|
C4542
|
|
Cyclobenzaprine hydrochloride
|
Skeletal muscle relaxant; reduces muscle spasm by depression of brainstem neurons; 5-HT2 serotonin receptor antagonist.
|
human ... HTR2A(3356), HTR2B(3357), HTR2C(3358)
|
|
|
|
|
C6022
|
|
Cyproheptadine hydrochloride sesquihydrate ≥98% (TLC), solid
|
5-HT2/5-HT1C serotonin receptor antagonist; H1 histamine receptor antagonist; antipruritic.
|
human ... HRH1(3269), HTR2A(3356), HTR2B(3357), HTR2C(3358)
|
|
|
|
|
D5676
|
|
N-Desmethylclozapine
|
Major metabolite of clozapine; potent 5-HT2 serotonin receptor antagonist and a ligand for the cloned 5-HT6 and 5-HT7 serotonin receptors. Also an allosteric potentiator of M1 muscarinic receptors.
|
human ... KCNH1(3756)
|
|
|
|
|
D9571
|
|
Dolasetron mesylate hydrate ≥98% (HPLC), powder
|
Dolasetron mesylate hydrate is a highly specific and selective serotonin 5-HT3 receptor antagonist, not shown to have activity at other known serotonin receptors and with low affinity for dopamine receptors.
|
|
|
|
|
|
G5918
|
|
GR 113808 ≥98% (HPLC), solid
|
GR 113808 is a 5-HT4 serotonin receptor antagonist.
|
human ... HTR4(3360) rat ... Htr3a(79246), Htr4(25324)
|
|
|
|
|
G5793
|
|
GR 127935 hydrochloride hydrate >98% (HPLC), solid
|
Potent, selective and orally active 5-HT1B/1D serotonin receptor antagonist.
|
human ... HTR1B(3351), HTR1D(3352)
|
|
|
|
|
G0419
|
|
GR 55562 dihydrobromide >97% (HPLC), powder
|
5-HT1B/5-HT1D serotonin receptor antagonist
|
|
|
|
|
|
G3796
|
|
Granisetron hydrochloride ≥98% (HPLC), solid
|
Granisetron hydrochloride is a serotonin 5-HT3 receptor antagonist and antiemetic.
|
|
|
|
|
|
L2536
|
|
LY-310,762 hydrochloride white powder
|
Potent, selective 5-HT1D serotonin receptor antagonist.
|
human ... HTR1D(3352)
|
|
|
|
|
L2411
|
|
LY-367,265
|
Antidepressant, inhibits the serotonin transporter; 5-HT2A serotonin receptor antagonist.
|
human ... HTR2A(3356)
|
|
|
|
|
SML0115
|
|
MDL 11939 ≥98% (HPLC)
|
MDL 11,939 is a potent, selective and orally active 5-HT2 receptor antagonist (ASTAR). Ki values values are in the low nanomolar range for 5-HT2A with over 100-fold selectivity over 5-HT2C receptors and low or no affinity for non-5-HT2 receptors or transporters.
|
|
|
|
|
|
M3668
|
|
Metergoline
|
Antagonist at 5-HT1, 5-HT2, and 5-HT7 serotonin receptors; analgesic; antipyretic.
|
human ... HTR1A(3350), HTR1B(3351), HTR1D(3352), HTR1E(3354), HTR1F(3355), HTR2A(3356), HTR2B(3357), HTR2C(3358), HTR7(3363) rat ... Htr7(65032)
|
|
|
|
|
M149
|
|
Methiothepin mesylate salt ≥98% (HPLC), solid
|
Methiothepin mesylate salt is a 5-HT1, 5-HT6, 5-HT7 serotonin receptor antagonist, which blocks serotonin autoreceptors.
|
human ... HTR1A(3350), HTR1B(3351), HTR1D(3352), HTR1E(3354), HTR1F(3355), HTR6(3362), HTR7(3363)
|
|
|
|
|
M137
|
|
Methysergide maleate salt solid
|
Nonselective 5-HT1, 5-HT2, and 5-HT7 serotonin receptor antagonist; antimigraine.
|
human ... HTR1A(3350), HTR1B(3351), HTR1D(3352), HTR1E(3354), HTR1F(3355), HTR2A(3356), HTR2B(3357), HTR2C(3358), HTR7(3363)
|
|
|
|
|
M2525
|
|
Mianserin hydrochloride
|
Antidepressant; antagonist/inverse agonist at 5-HT2 serotonin receptors; also blocks the H1 histamine receptor and the α2 adrenoceptor.
|
human ... ADRA2A(150), ADRA2B(151), ADRA2C(152), HRH1(3269), HTR2A(3356), HTR2B(3357), HTR2C(3358)
|
|
|
|
|
M226
|
|
p-MPPF dihydrochloride solid
|
Selective 5-HT1A serotonin receptor antagonist. More potent than p-MPPI.
|
human ... HTR1A(3350)
|
|
|
|
|
N3529
|
|
NAN-190 hydrobromide
|
Potent 5-HT1A serotonin receptor antagonist active in the nM range.
|
human ... HTR1A(3350)
|
|
|
|
|
P0667
|
|
Parthenolide ≥98% (HPLC)
|
Anti-inflammatory agent that inhibits NF-κB activation.
|
human ... ELA2(1991), IKBKG(8517), NFKB1(4790), NKAP(79576), NKRF(55922)
|
|
|
|
|
P126
|
|
Pirenperone >97%, solid
|
5-HT2 serotonin receptor antagonist.
|
human ... HTR2A(3356), HTR2B(3357), HTR2C(3358)
|
|
|
|
|
B9688
|
|
Pizotifen ≥98% (HPLC)
|
Pizotifen is a serotonin antagonist acting mainly at the 5-HT1, 5-HT2A and 5HT2C receptors with some antihistamine activity. It is used for the prevention of vascular headache including migraine and cluster headache.
|
|
|
|
|
|
R3030
|
|
Risperidone ≥98% (HPLC), powder
|
Risperidone is an antipsychotic; serotonin-dopamine antagonist.
|
|
|
|
|
|
R103
|
|
Ritanserin powder
|
Potent 5-HT2A serotonin receptor antagonist/inverse agonist that crosses the blood-brain barrier.
|
human ... HTR2A(3356) rat ... Adra1a(29412), Drd2(24318), Htr1a(24473), Htr2a(29595), Htr7(65032)
|
|
|
|
|
R140
|
|
Ro 04-6790 dihydrochloride solid
|
Selective 5-HT6 serotonin receptor antagonist.
|
human ... HTR6(3362)
|
|
|
|
|
R2533
|
|
RS-127445 hydrochloride ≥98% (HPLC), powder
|
RS-127445 is a selective; high affinity; orally bioavailable serotonin 5-HT2B receptor antagonist. RS-127445 was found to have nanomolar affinity for the 5-HT2B receptor (pKi=9.5) and 1,000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites.
|
|
|
|
|
|
S3313
|
|
SB-204070 hydrochloride solid, ≥97% (HPLC)
|
Selective 5-HT4 serotonin receptor antagonist.
|
human ... HTR4(3360)
|
|
|
|
|
S0693
|
|
SB 204741 >98% (HPLC)
|
5-HT2B serotonin receptor antagonist.
|
human ... DRD2(1813), DRD3(1814), DRD5(1816), HTR1E(3354), HTR2A(3356), HTR2B(3357), HTR2C(3358) rat ... Adra1a(29412), Gabra2(29706), Htr1a(24473), Htr2b(29581), Htr3a(79246)
|
|
|
|
|
S180
|
|
SB-206553 hydrochloride hydrate ≥98% (HPLC), solid
|
Potent 5-HT2B/5-HT2C serotonin receptor antagonist.
|
human ... HTR2B(3357), HTR2C(3358)
|
|
|
|
|
S1068
|
|
SB-215505 solid, >98% (HPLC)
|
Selective 5-HT2B serotonin receptor antagonist; 100-fold higher affinity at 2B versus 2C.
|
human ... HTR2B(3357)
|
|
|
|
|
S8061
|
|
SB 242084 dihydrochloride hydrate ≥98% (HPLC), powder
|
Selective 5-HT2c serotonin receptor antagonist; crosses the blood-brain barrier.
|
|
|
|
|
|
S1194
|
|
SB-258585 dihydrochloride ≥98% (HPLC), powder
|
5-HT6 serotonin receptor antagonist.
|
|
|
|
|
|
S174
|
|
SDZ-205,557 hydrochloride solid
|
Potent, selective 5-HT4 serotonin receptor antagonist.
|
human ... HTR4(3360)
|
|
|
|
|
S8072
|
|
Sertindole ≥97.5% (HPLC)
|
Sertindole is a 5-HT2 serotonin and D2 dopamine receptor antagonist and antipsychotic.
|
|
|
|
|
|
T104
|
|
Tropisetron monohydrochloride solid, ≥98% (HPLC)
|
3-Tropanylindole-3-carboxylate hydrochloride is a selective 5-HT3 serotonin receptor antagonist. Tropisetron a selective serotonin 5-HT3 receptor antagonist is used mainly as an antiemetic to treat nausea and vomiting following chemotherapy . In the treatment of fibromyalgia syndrome (FMS) tropisetron reduced not only pain perception but also had a favourable effect on cardiac dysfunction during treatment.
|
human ... CHRNA3(1136), CHRNA4(1137), CHRNB2(1141), CHRNB4(1143), HTR3A(3359), HTR3B(9177), HTR3C(170572), HTR3D(200909), HTR3E(285242) rat ... Chrna7(25302), Drd2(24318), Htr1a(24473), Htr3a(79246)
|
|
|
|
|
U108
|
|
S(−)-UH-301 hydrochloride solid
|
Potent, selective 5-HT1A serotonin receptor antagonist; D2/D3 dopamine receptor agonist.
|
human ... HTR1A(3350)
|
|
|
|
|
W108
|
|
WAY-100635 maleate salt powder
|
WAY-100635 maleate salt is a highly selective 5-HT1A serotonin receptor antagonist.
|
human ... HTR1A(3350)
|
|
|
|
|
W0270
|
|
WAY 161503 hydrochloride ≥98% (HPLC)
|
The 5-HT2C receptors have been implicated in conditions including obesity, anxiety, depression, OCD, schizophrenia, migraine, nociception and erectile dysfunction.
|
|
|
|
|
|
SML0081
|
|
Zacopride hydrochloride hydrate ≥98% (HPLC)
|
Zacopride is a sub-nanomolar antagonist of the serotonin 5-HT3 receptor that also displays agonist-like activity against 5-HT4 receptors. It is a potent anxiolytic in animal models, and also has strong antiemetic effects, and also increases aldosterone levels via activation of 5-HT4 receptor in the adrenal glands.
|
|
|
|
|
|
Z2777
|
|
Ziprasidone hydrochloride monohydrate ≥98% (HPLC), solid
|
Ziprasidone is an atypical antipsychotic; FDA approved for the treatment of schizophrenia.
|
|
|
|
|